Clinical efficacy and safety of pembrolizumab and nivolumab in frontline treatment for classical Hodgkin lymphoma: systematic review and meta-analysis of clinical trials - Top-Institutions - MDSpire

Clinical efficacy and safety of pembrolizumab and nivolumab in frontline treatment for classical Hodgkin lymphoma: systematic review and meta-analysis of clinical trials

  • By

  • Artem Oganesyan

  • Andrew Gregory

  • Mark Gregory

  • Deivid Badalian

  • Asatur Chakmanyan

  • Lusine Harutyunyan

  • Vahe Khachatryan

  • Abhay Aradhya

  • Aheed Javaid

  • Yervand Hakobyan

  • Christian J Fidler

  • Pierluigi Porcu

  • June 26, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    City of Hope National Medical Center
    City of Hope National Medical Center

    Duarte, California

    Key Differentiators

    • Hematology
    • Oncology

  • #2

    Central Clinical School of the University of Sydney
    Central Clinical School of the University of Sydney

    Sydney, New South Wales

    Key Differentiators

    • Hematology
    • Oncology

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Hematology
    • Oncology

  • #4

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Hematology
    • Oncology

  • #5

    Yale Cancer Center
    Yale Cancer Center

    New Haven, Connecticut

    Key Differentiators

    • Hematology
    • Oncology

Original Source(s)

Clinical efficacy and safety of pembrolizumab and nivolumab in frontline treatment for classical Hodgkin lymphoma: systematic review and meta-analysis of clinical trials

  • by Artem Oganesyan, Andrew Gregory, Mark Gregory, Deivid Badalian, Asatur Chakmanyan, Lusine Harutyunyan, Vahe Khachatryan, Abhay Aradhya, Aheed Javaid, Yervand Hakobyan, Christian J Fidler, Pierluigi Porcu

  • June 26, 2026

Related Content

Adrenal tumor microenvironment: hormone–immune crosstalk, molecular heterogeneity, and immunotherapeutic opportunities

FAD-YOLO: a lightweight feature-refined and task-aligned framework for AIS–MIA discrimination on pulmonary CT

Case Report: Metastatic pancreatic ductal adenocarcinoma initially masked by multiple gastroduodenal ulcers with apparent endoscopic healing: a diagnostic pitfall